Company Nang Kuang Pharmaceutical Co., Ltd.

Company Nang Kuang Pharmaceutical Co., Ltd.

1752

TW0001752004

Pharmaceuticals

Equities

1752

TW0001752004

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Quarterly revenue - Rate of surprise

Sector Other Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Quarterly revenue - Rate of surprise

Sector Other Pharmaceuticals

End-of-day quote Taiwan S.E. Other stock markets 18:00:00 2024-05-09 EDT			5-day change	1st Jan Change
45.45 ^TWD	+1.56%		+1.91%	-14.73%

05-08	Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-26	Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

NANG KUANG PHARMACEUTICAL CO., LTD. is principally engaged in the manufacture, processing and trading of western medicine. The company main products include injections, sterile injections, powder injections, hard capsules, bare ingots, film ingots, casing ingots, granules and creams, among others. The Company is also engaged in the manufacture, processing and trading of medical equipment. The Company distributes its products within the domestic market and to overseas markets.

Number of employees: 552

TWD in Million	2022	Weight	2023	Weight	Delta
Injections of Western Medicines 100.0 %	1,940	100.0 %	2,150	100.0 %	+10.81%

TWD in Million	2022	Weight	2023	Weight	Delta
Taiwan 66.1 %	1,306	67.3 %	1,421	66.1 %	+8.76%
China 18.9 %	184	9.5 %	407	18.9 %	+121.19%
Japan 9.6 %	241	12.4 %	207	9.6 %	-14.05%
United States 2.8 %	174	9.0 %	60	2.8 %	-65.33%
Other Countries 2.5 %	35	1.8 %	54	2.5 %	+56.39%

Managers	Title	Age	Since
Yue Pei Wang CEO	Chief Executive Officer	-	02-08-31
Wen Yung Tsai DFI	Director of Finance/CFO	-	10-07-31
Li Hsien Chen CHM	Chairman	-	05-07-09
Guei-Fen Wang ADM	Chief Administrative Officer	-	22-03-31
Pen Sung Chen BRD	Director/Board Member	-	14-06-24
Pen Chung Chen IRO	Public Communications Contact	-	04-09-30
Chi Ren Song SAM	Sales & Marketing	-	-
Ben long Chen PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Chao Chin Wang BRD	Director/Board Member	-	14-06-24
Li Hsien Chen CHM	Chairman	-	05-07-09
Yue Pei Wang CEO	Chief Executive Officer	-	02-08-31
Pen Sung Chen BRD	Director/Board Member	-	14-06-24
Po Jen Chang BRD	Director/Board Member	-	20-05-26
Er-Lang Su BRD	Director/Board Member	-	07-06-24
Chih Lung Lin BRD	Director/Board Member	-	12-06-05

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	100,989,000	44,890,472 ( 44.45 %)	0	44.45 %

Name	Equities	%	Valuation
Pennsylvania State Employees' Retirement System 0.1832 %	185,000	0.1832 %	271 401 NT$
Hua Nan Securities Investment Trust Co. Ltd. 0.1485 %	150,000	0.1485 %	220 055 NT$
Taichung Bank Securities Investment Trust Co., Ltd. 0.0565 %	57,085	0.0565 %	83 745 NT$
Dimensional Fund Advisors Ltd. 0.0139 %	14,020	0.0139 %	20 568 NT$
DFA Australia Ltd. 0.002931 %	2,960	0.002931 %	4 342 NT$

Nang Kuang Pharmaceutical Co., Ltd.

1001 Chungshan Road Xinhua District

712 43, Tainan

http://www.nangkuang.com.tw

address Nang Kuang Pharmaceutical Co., Ltd.(1752)

Company calendar

	1st Jan change	Capi.
NANG KUANG PHARMACEUTICAL CO., LTD.	-14.73%	141M
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals